FOGHORN THERAPEUTICS INC (FHTX) Stock Analyst Earnings Estimates
NASDAQ:FHTX - Nasdaq - US3441741077 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.32M 206.98% | 19.23M 1,356.82% | 34.155M 77.61% | 31.694M -7.21% | 34.029M 7.37% | 41.066M 20.68% | 42.97M 4.64% | 60.413M 40.59% | 106.3M 75.96% | 93.746M -11.81% | 194.52M 107.50% | 339M 74.28% | |
| EBITDA YoY % growth | -97.54M -45.08% | -113.84M -16.71% | -104.455M 8.24% | -96.151M 7.95% | -102.511M -6.61% | -102.393M 0.11% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -100.74M -47.00% | -117.14M -16.28% | -107.906M 7.88% | -103.977M 3.64% | -98.75M 5.03% | -102.701M -4.00% | -145.718M -41.89% | -117.665M 19.25% | -93.387M 20.63% | -149.01M -59.56% | -59.056M 60.37% | 73.408M 224.30% | |
| Operating Margin | -7,631.82% | -609.15% | -315.93% | -328.06% | -290.19% | -250.09% | -339.11% | -194.77% | -87.85% | -158.95% | -30.36% | 21.65% | |
| EPS YoY % growth | -2.70 39.94% | -2.62 2.96% | -2.34 10.69% | -1.68 28.39% | -1.42 15.11% | -1.52 -6.60% | -2.05 -35.42% | -1.71 16.89% | -1.32 22.71% | -2.53 -92.14% | -1.10 56.54% | 1.30 217.59% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.39 32.36% | -0.42 28.02% | -0.43 5.10% | -0.43 -38.52% | -0.33 13.89% | -0.35 18.33% | -0.35 18.79% | -0.36 16.86% | -0.33 1.69% |
| Revenue Q2Q % growth | 7.232M 25.36% | 6.108M 20.95% | 6.218M -9.73% | 6.333M -18.89% | 10.01M 38.41% | 16.32M 167.19% | 16.32M 162.46% | 16.32M 157.70% | 16.32M 63.04% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -28.636M -12.48% | -30.432M -7.94% | -30.935M -27.65% | -32.159M -34.83% | -31.051M -8.43% | -20.969M 31.10% | -21.341M 31.01% | -21.718M 32.47% | -22.098M 28.83% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.31 8.82% | -0.45 | 0.14 | 30.99% |
| Q2 2024 Q2Q % growth | -0.45 35.71% | -0.67 | 0.22 | 32.64% |
| Q1 2024 Q2Q % growth | -0.59 19.18% | -0.65 | 0.06 | 8.69% |
| Q4 2023 Q2Q % growth | -0.57 17.39% | -0.78 | 0.21 | 26.78% |
| Q3 2023 Q2Q % growth | -0.34 45.16% | -0.76 | 0.42 | 55.54% |
| Q2 2023 Q2Q % growth | -0.70 -6.06% | -0.75 | 0.05 | 6.63% |
| Q1 2023 Q2Q % growth | -0.73 -12.31% | -0.74 | 0.01 | 1.28% |
| Q4 2022 Q2Q % growth | -0.69 6.76% | -0.63 | -0.06 | -9.46% |
| Q3 2022 Q2Q % growth | -0.62 12.68% | -0.63 | 0.01 | 1.96% |
| Q2 2022 Q2Q % growth | -0.66 -4.76% | -0.60 | -0.06 | -9.21% |
| Q1 2022 Q2Q % growth | -0.65 -4.84% | -0.53 | -0.12 | -21.96% |
| Q4 2021 Q2Q % growth | -0.74 60.22% | -0.50 | -0.24 | -48.67% |
| Q3 2021 Q2Q % growth | -0.71 77.24% | -0.68 | -0.03 | -4.41% |
| Q2 2021 Q2Q % growth | -0.63 | -0.64 | 0.01 | 1.44% |
| Q1 2021 Q2Q % growth | -0.62 | -0.64 | 0.02 | 3.52% |
| Q4 2020 Q2Q % growth | -1.86 | -0.46 | -1.40 | -305.23% |
| Q3 2020 Q2Q % growth | -3.12 | -1.75 | -1.37 | -77.84% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 7.808M -55.33% | 6.465M | 1.343M | 20.77% |
| Q2 2024 Q2Q % growth | 6.888M 23.02% | 6.161M | 727K | 11.80% |
| Q1 2024 Q2Q % growth | 5.05M -4.88% | 7.05M | -2M | -28.37% |
| Q4 2023 Q2Q % growth | 5.769M 38.01% | 4.714M | 1.055M | 22.38% |
| Q3 2023 Q2Q % growth | 17.478M 163.62% | 4.611M | 12.867M | 279.05% |
| Q2 2023 Q2Q % growth | 5.599M 24.70% | 6.388M | -789K | -12.35% |
| Q1 2023 Q2Q % growth | 5.309M 35.43% | 5.138M | 171K | 3.33% |
| Q4 2022 Q2Q % growth | 4.18M 488.73% | 8.648M | -4.468M | -51.67% |
| Q3 2022 Q2Q % growth | 6.63M 16,475.00% | 9.384M | -2.754M | -29.35% |
| Q2 2022 Q2Q % growth | 4.49M 1,503.57% | 8.861M | -4.371M | -49.33% |
| Q1 2022 Q2Q % growth | 3.92M 1,251.72% | 8.619M | -4.699M | -54.52% |
| Q4 2021 Q2Q % growth | 710K 184.00% | 165.75K | 544.25K | 328.36% |
| Q3 2021 Q2Q % growth | 40K -77.78% | 170.003K | -130.003K | -76.47% |
| Q2 2021 Q2Q % growth | 280K | 255K | 25K | 9.80% |
| Q1 2021 Q2Q % growth | 290K | 170.003K | 119.997K | 70.58% |
| Q4 2020 Q2Q % growth | 250K | 510K | -260K | -50.98% |
| Q3 2020 Q2Q % growth | 180K | 510K | -330K | -64.71% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 17.33% | 0% | 15.81% |
| Revenue | 0% | 8.26% | 0% | 0.69% |